Skip to main content

Ethan Byler, Hermann Hauser, Mary Archer, Ramond Bonner, Edward Poplawski, Monica Kreuger, Lanis Anthony, Chad Blenkin, Keith Brown, Susan Gorges, James Mason, Georgette Nocolas, Cherylynn Walters, Susan Zwarych

Premium

Pa. Biotech Center of Bucks County Names New Director of Biotech Development
 
Ethan Byler has joined the Pennsylvania Biotechnology Center of Bucks County, a translational research center, as its director of biotechnology development. His activities will include new business development, technology transfer, coordination of activities within the state economic development Keystone Innovation Zone, and working with the Regional Biotechnology Council, which supports biotech entrepreneurs in the Southeastern Pennsylvania counties of Chester, Montgomery, Delaware, Philadelphia, and Bucks.
 
Byler joins the Pennsylvania Biotechnology Center from New Economy Strategies, a Washington, DC, consulting company focused on technology-based economic development. His activities there included management of regional innovation and growth projects; initiatives focusing on capital formation and entrepreneurship; rural economic development and the design of administration-led interventions in technology; and innovation-based economic development.
 
Byler has worked on tech-based economic development strategies in Pennsylvania, New Jersey, New Mexico, Alabama, Kentucky, Connecticut, Utah, North Carolina, Michigan, and Colorado; as well as a number of advanced technical assistance engagements to the US Department of Labor’s Workforce Innovation in Regional Economic Development, or WIRED, program.
 
Earlier, Byler served as an analyst with federal funding programs for the regional economic development organization Innovation Philadelphia. There, he provided technical support on grant applications, business plans, and the presentation materials of early-stage companies attempting to secure financing through private investment or Small Business Innovation Research grants.
 
Byler, a Doylestown, Pa., resident, holds a masters degree in government administration from the Fels Institute of Government at the University of Pennsylvania; and a bachelors degree from the University of Charleston.
 

 
Hermann Hauser becomes new Chairman of East of England Stem Cell Network
 
Hermann Hauser, a co-founder of the Cambridge, UK-based venture capital firm Amadeus Capital Partners, has been named chairman of the East of England Stem Cell Network. EESCN focuses on ensuring that the East of England generates medicines and other benefits from stem cell science.
 
Hauser succeeds Mary Archer, chairman of Addenbrooke’s Cambridge University Hospitals National Health Service Trust, who steered the network from a government-funded initiative in 2004 to a private, not-for-profit company with over 500 members. Archer will remain active in the network as a member of its steering group.
 
Hauser co-founded Amadeus in 1997 with Anne Glover and Peter Wynn. During his years as an entrepreneur and venture capitalist, he has founded or co-founded two life sciences companies, IQ Bio and SynGenix; among eight tech-based businesses.
 
At Amadeus, Hauser has been a non-executive director of several investee companies. He was a non-executive director of Solexa, a developer of ultra-high throughput DNA sequencing technology that was acquired by Illumina in 2007; and Plastic Logic, which has developed a process for producing flexible plastic transistors for use in computer displays.
 
Hauser holds an MA in physics from Vienna University and a PhD in physics from the Cavendish Laboratory at King's College, Cambridge. He is a Fellow of the Institute of Physics and of the Royal Academy of Engineering and an Honorary Fellow of King's College, Cambridge.
 
Hauser holds honorary doctorates from the Universities of Bath, Loughborough, and from Anglia Polytechnic, and was awarded an Honorary CBE for “innovative service to the UK enterprise sector” in 2001. In 2004, he was made a member of the Government’s Council for Science & Technology.
 

 
Sidley Austin Adds Two Executive Committee Members With Life Sciences Experience
 
The law firm Sidley Austin has added to its executive committee two new members with experience in the life sciences, bringing its number to 49 members:
  • Raymond Bonner, a partner based at the law firm’s Washington, DC, office, is global coordinator of the firm's FDA Regulatory practice and focuses his practice on FDA and healthcare-related litigation, government and grand jury investigations, and regulatory enforcement matters. He has counseled pharmaceutical, medical device and biologics companies concerning product applications and requirements, good manufacturing and quality systems practices, and drug safety requirements. Bonner regularly conducts internal and compliance-related investigations for multinational life sciences companies.
  • Edward Poplawski, a partner based at the firm’s Los Angeles offices, is global coordinator of Sidley Austin’s intellectual property litigation practice. His practice focuses on intellectual property and technology, predominantly patent litigation, including jury trials and proceedings before the International Trade Commission. He has prepared and prosecuted patent and trademark applications, as well as licensing technology ranging from biotechnology to software and electronics. Poplawski is a member of the firm's practice development committee and a member of the firm's computers and legal technology committee.

 
Saskatchewan Entrepreneurship Council Names Nine Members
 
Nine members of the Saskatchewan Entrepreneurship Council, one of several councils operating under the new economic development agency, Enterprise Saskatchewan, were announced last week. The council will advise Enterprise Saskatchewan on issues that encourage or deter people from becoming entrepreneurs in the province.
 
The council’s members:
  • Monica Kreuger, president of Global Infobrokers, a private entrepreneurship training institute in Saskatchewan, and the founder of a business plan competition, Venture Forward, which provides a CAN$100,000 ($78,386) cash award to contest winners to help them start their businesses in Saskatchewan.
  • Lanis Anthony, principal of CCINC Group of Companies and director of Saskatchewan Angel Investors Network, known as SAINT. She is an angel investor, as well as a mentor, board member, and adviser, to a variety of businesses.
  • Chad Blenkin, president of Urban Roots Media and an executive board member of Saskatchewan Young Professionals and Entrepreneurs.
  • Keith Brown, founder and CEO of Trailtech, Canada's largest manufacturer of light commercial trailers, and chair of the board of directors for the Entrepreneurial Foundation of Saskatchewan.
  • Susan Gorges, CEO of the technology accelerator SpringBoard West Innovations, and formerly a technology commercialization advisor at the Los Alamos National Laboratory.
  • James Mason, business professor at the Paul J. Hill School of Business, University of Regina. Mason has been a professor for 30 years and served as assistant, associate and acting dean of the Faculty of Business Administration at the U of R.
  • Georgette Nicolas, senior business development specialist, Clarence Campeau Development Fund, established to improve the economic conditions of Saskatchewan's Metis.
  • Cherylynn Walters, manager of the Marieval Enterprise Centre, and formerly vice president of marketing for an undisclosed Saskatchewan biotechnology company.
  • Susan Zwarych, president and CEO, Mondovi Publishing, which produces Saskatoon Home Magazine, and Mondovi Property Developments, a home improvement consultant and contractor. She also chairs the Board of Ideas, a non-profit business incubator in Saskatoon.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.